COMPASS THERAPEUTICS, INC. (CMPX) Return on equity 2023–2025
COMPASS THERAPEUTICS, INC. (CMPX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-33.8%FY2025 · since FY2023: -28.6% → -33.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -33.8% | +5.6 pp |
| FY2024 | -39.4% | -10.8 pp |
| FY2023 | -28.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CMPX financial trends
CMPX RevenueCMPX Net incomeCMPX Net marginCMPX Gross profitCMPX Gross marginCMPX Operating incomeCMPX Operating marginCMPX Operating cash flowCMPX Free cash flowCMPX Capital expendituresCMPX Stock buybacksCMPX Dividends paidCMPX Total assetsCMPX Total liabilitiesCMPX Shareholders’ equityCMPX overview →